Page last updated: 2024-08-16

rivastigmine and om99-2

rivastigmine has been researched along with om99-2 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Akbarzadeh, T; Edraki, N; Foroumadi, A; Karimpor-Razkenari, E; Khanavi, M; Mahdavi, M; Moghadam, FH; Najafi, Z; Sabourian, R; Saeedi, M; Shafiee, A; Sharifzadeh, M; Tehrani, MB	1

Other Studies

1 other study(ies) available for rivastigmine and om99-2

Article	Year
Design and synthesis of novel anti-Alzheimer's agents: Acridine-chromenone and quinoline-chromenone hybrids. Bioorganic chemistry, 2016, Volume: 67 Topics: Acridines; Alzheimer Disease; Animals; Cholinesterase Inhibitors; Cholinesterases; Chromones; Dose-Response Relationship, Drug; Drug Design; Humans; Models, Molecular; Molecular Structure; Neuroprotective Agents; PC12 Cells; Quinolines; Rats; Structure-Activity Relationship	2016

Article

Year

Design and synthesis of novel anti-Alzheimer's agents: Acridine-chromenone and quinoline-chromenone hybrids.

Bioorganic chemistry, 2016, Volume: 67

Topics: Acridines; Alzheimer Disease; Animals; Cholinesterase Inhibitors; Cholinesterases; Chromones; Dose-Response Relationship, Drug; Drug Design; Humans; Models, Molecular; Molecular Structure; Neuroprotective Agents; PC12 Cells; Quinolines; Rats; Structure-Activity Relationship

2016